What smart money is saying about LeMaitre Vascular, Inc.
LMAT
No fund has written a full thesis on LeMaitre Vascular, Inc. in our archive, but 3 fund letters report a position in it — most recently Riverwater Partners Micro Opportunities Strategy in June 2026.
Get an email when a fund writes about it
3
Reported positions
0
Bought
0
Sold
3
Letters
Position history
Every position in LeMaitre Vascular, Inc. on record in the archive was reported in Q2 2026, across 3 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 3 | 0 | 0 | 0 |
Fund activity · 3 positions
- June 2026
Listed in Riverwater Partners Micro Opportunities Strategy’s reported holdings.
LeMaitre Vascular, Inc. - June 2026
“LeMaitre Vascular (LMAT) LeMaitre Vascular, our peripheral vascular device holding, declined approximately 12% in a quarter when nearly everything profitable in small cap health care went down and nearly everything speculative went up.”
LeMaitre Vascular, Inc. - HoldsBridge City Capital Small Cap Growth CompositeJune 2026
“-0.2%1.4%LeMaitre Vascular, Inc.”
LeMaitre Vascular, Inc.
Read the letters behind these LeMaitre Vascular, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger